Jazz Pharmaceuticals to Present Extensive New Data and Real-World Evidence Highlighting Epidiolex® (cannabidiol) Outcomes in Treatment-Resistant Epilepsies at the American ...

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that eight abstracts, including four that are late-breaking, will be presented on Epidiolex® (cannabidiol) at the American Epilepsy Society (AES ...
Multiple Sclerosis News Today

Oral bacteria tied to more severe multiple sclerosis symptoms

Researchers report that elevated levels of the oral bacteria Fusobacterium nucleatum may be linked with greater disability in ...
The Lancet

Blood and CSF biomarkers for multiple sclerosis: emerging clinical applications

eMultiple Sclerosis Centre and Research Center for Clinical Neuroimmunology and Neuroscience (RC2NB), Departments of Biomedicine and Clinical Research, University Hospital and University of Basel, ...